First novel steroid-free topical with a new mechanism of action approved for plaque psoriasis in over 25 yearsFirst ZORYVE approval outside of the U.S. marks key milestone for Arcutis WESTLAKE. | April 28, 2023
The findings are important, since many regulatory bodies require patients to try first-line conventional systemic therapies before novel therapeutics, the lead investigator explained.